Cleared Traditional

K931421 - DISPOSABLE STEERABLE ANGIOSCOPE

K931421 is an FDA 510(k) clearance for DISPOSABLE STEERABLE ANGIOSCOPE, manufactured by Endovascular, Inc.. The device is a Class 2 Cardiovascular device with product code LYK cleared through the Traditional 510(k) pathway after a 86-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1993
Decision
86d
Days
Class 2
Risk

K931421 is an FDA 510(k) clearance for the DISPOSABLE STEERABLE ANGIOSCOPE. Classified as Angioscope (product code LYK), Class II - Special Controls.

Submitted by Endovascular, Inc. (Costa Mesa, US). The FDA issued a Cleared decision on June 16, 1993 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 876.1500 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Endovascular, Inc. devices

FDA 510(k) Submission Details - K931421

510(k) Number K931421 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 1993
Decision Date June 16, 1993
Days to Decision 86 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 125d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LYK Device Classification - Class 2, Special Controls

Product Code LYK Angioscope
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LYK Angioscope

All 24
Devices cleared under the same product code (LYK) and FDA review panel - the closest regulatory comparables to K931421.
APPLIED MEDICAL OPTICAL VALVULOTOME
K945591 · Applied Medical Resources · Feb 1995
BAXTER CORONARY ANGIOSCOPE INFLATION DEVICE
K931464 · Baxter Healthcare Corp · Oct 1993
DIAGNOSTIC INTRAVASCULAR CATHETER
K930758 · Applied Medical Resources · Sep 1993
CLARUS SERIRS 2200 SEMI-RIGID ENDOSCOPE
K924554 · Clarus Medical Systems, Inc. · Feb 1993
OLYMPUS AF ANGIOSCOPE SYSTEM
K911278 · Olympus Corp. · Jul 1991
4.5F IMAGECATH ANGIOSCOPE
K905083 · Baxter Healthcare Corp · Jun 1991